Insulet Corporation

NasdaqGS:PODD Stock Report

Market Cap: US$18.6b

Insulet Future Growth

Future criteria checks 1/6

Insulet is forecast to grow earnings and revenue by 1.6% and 14.3% per annum respectively. EPS is expected to decline by 0.8% per annum. Return on equity is forecast to be 19.9% in 3 years.

Key information

1.6%

Earnings growth rate

-0.8%

EPS growth rate

Medical Equipment earnings growth17.1%
Revenue growth rate14.3%
Future return on equity19.9%
Analyst coverage

Good

Last updated12 Dec 2024

Recent future growth updates

Recent updates

Here's Why Insulet (NASDAQ:PODD) Can Manage Its Debt Responsibly

Dec 18
Here's Why Insulet (NASDAQ:PODD) Can Manage Its Debt Responsibly

Here's Why Insulet (NASDAQ:PODD) Has Caught The Eye Of Investors

Dec 04
Here's Why Insulet (NASDAQ:PODD) Has Caught The Eye Of Investors

Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines

Nov 20

Does This Valuation Of Insulet Corporation (NASDAQ:PODD) Imply Investors Are Overpaying?

Nov 20
Does This Valuation Of Insulet Corporation (NASDAQ:PODD) Imply Investors Are Overpaying?

Returns At Insulet (NASDAQ:PODD) Are On The Way Up

Nov 08
Returns At Insulet (NASDAQ:PODD) Are On The Way Up

Market Participants Recognise Insulet Corporation's (NASDAQ:PODD) Revenues

Oct 15
Market Participants Recognise Insulet Corporation's (NASDAQ:PODD) Revenues

Is There Now An Opportunity In Insulet Corporation (NASDAQ:PODD)?

Oct 03
Is There Now An Opportunity In Insulet Corporation (NASDAQ:PODD)?

Is Insulet (NASDAQ:PODD) A Risky Investment?

Sep 09
Is Insulet (NASDAQ:PODD) A Risky Investment?

Insulet: Turning More Constructive, Valuations Still Stretched

Sep 05

Here's Why We Think Insulet (NASDAQ:PODD) Is Well Worth Watching

Aug 28
Here's Why We Think Insulet (NASDAQ:PODD) Is Well Worth Watching

Additional Considerations Required While Assessing Insulet's (NASDAQ:PODD) Strong Earnings

Aug 16
Additional Considerations Required While Assessing Insulet's (NASDAQ:PODD) Strong Earnings

A Look At The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)

Jul 15
A Look At The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)

Insulet Corporation: Insulin Pump Provider Fighting Back After Torrid 2023

Jun 11

We Like These Underlying Return On Capital Trends At Insulet (NASDAQ:PODD)

May 26
We Like These Underlying Return On Capital Trends At Insulet (NASDAQ:PODD)

At US$166, Is It Time To Put Insulet Corporation (NASDAQ:PODD) On Your Watch List?

May 12
At US$166, Is It Time To Put Insulet Corporation (NASDAQ:PODD) On Your Watch List?

Is Insulet (NASDAQ:PODD) A Risky Investment?

Apr 29
Is Insulet (NASDAQ:PODD) A Risky Investment?

Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors

Apr 14
Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors

Estimating The Fair Value Of Insulet Corporation (NASDAQ:PODD)

Mar 31
Estimating The Fair Value Of Insulet Corporation (NASDAQ:PODD)

Insulet: Insulating Patients, Investors Still Have To Wait

Mar 28

Insulet (NASDAQ:PODD) Is Doing The Right Things To Multiply Its Share Price

Feb 19
Insulet (NASDAQ:PODD) Is Doing The Right Things To Multiply Its Share Price

Is Insulet Corporation (NASDAQ:PODD) Potentially Undervalued?

Jan 22
Is Insulet Corporation (NASDAQ:PODD) Potentially Undervalued?

Insulet: An Interesting, Yet Expensive, Story

Jan 10

Is Insulet (NASDAQ:PODD) Using Too Much Debt?

Jan 09
Is Insulet (NASDAQ:PODD) Using Too Much Debt?

Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors

Dec 27
Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors

Earnings and Revenue Growth Forecasts

NasdaqGS:PODD - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,84236743754219
12/31/20252,42228936246222
12/31/20242,05539829040121
9/30/20241,984421218328N/A
6/30/20241,873395182285N/A
3/31/20241,781234137233N/A
12/31/20231,69720637146N/A
9/30/20231,557120-15151N/A
6/30/20231,46563-26152N/A
3/31/20231,3681-45133N/A
12/31/20221,3055-38119N/A
9/30/20221,24317-6343N/A
6/30/20221,17835-141-40N/A
3/31/20221,14245-152-47N/A
12/31/20211,09917-191-68N/A
9/30/20211,037-29-199-26N/A
6/30/2021996-30-12644N/A
3/31/20219599-12053N/A
12/31/20209047-8284N/A
9/30/202086829-15114N/A
6/30/202082618-25101N/A
3/31/20207775-6588N/A
12/31/201973812-7298N/A
9/30/201969417-7482N/A
6/30/201965317-10367N/A
3/31/201960014-12647N/A
12/31/20185643-12636N/A
9/30/2018529-13-13027N/A
6/30/2018500-17N/A35N/A
3/31/2018486-23N/A59N/A
12/31/2017464-27N/A41N/A
9/30/2017437-29N/A39N/A
6/30/2017410-30N/A19N/A
3/31/2017387-26N/A5N/A
12/31/2016367-27N/A16N/A
9/30/2016347-34N/A-23N/A
6/30/2016324-49N/A-17N/A
3/31/2016297-62N/A-20N/A
12/31/2015264-62N/A-13N/A
9/30/2015253-51N/A11N/A
6/30/2015256-44N/A7N/A
3/31/2015268-56N/A6N/A
12/31/2014231-48N/A9N/A
9/30/2014285-49N/A1N/A
6/30/2014271-59N/A0N/A
3/31/2014259-40N/A4N/A
12/31/2013247-45N/A3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PODD's forecast earnings growth (1.6% per year) is below the savings rate (2.6%).

Earnings vs Market: PODD's earnings (1.6% per year) are forecast to grow slower than the US market (15.3% per year).

High Growth Earnings: PODD's earnings are forecast to grow, but not significantly.

Revenue vs Market: PODD's revenue (14.3% per year) is forecast to grow faster than the US market (9.1% per year).

High Growth Revenue: PODD's revenue (14.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: PODD's Return on Equity is forecast to be low in 3 years time (19.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/17 16:48
End of Day Share Price 2024/12/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Insulet Corporation is covered by 57 analysts. 22 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anand VankawalaAvondale Partners
Jeffrey JohnsonBaird
Ishan MajumdarBaptista Research